Loading...
Real-world experience of eltrombopag in immune thrombocytopenia
Immune thrombocytopenia (ITP) is characterized by decreased platelet count in the peripheral circulation. The first-line therapy is corticosteroids with 53-80% overall response rate. Eltrombopag has been used as second-line therapy in ITP for over a decade now. The long-term efficacy and safety prof...
Na minha lista:
| Udgivet i: | Am J Blood Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675127/ https://ncbi.nlm.nih.gov/pubmed/33224568 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|